CLINICAL_TRIALS
trial_result
· 2018-07-09
Clinical Trial Update: Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating oxidative stress markers in inherited homocystinuria and the impact of taurine; results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Homocystinuria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-07-09